New sublingual delivery system designed to enhance bioavailability and avoid gastric side effects many patients experience with clopidogrel.

Generic drug maker Apotex Inc. caught the market by surprise yesterday, launching a cheaper copy of the best-selling, blood thinner Plavix in the United States ahead of a likely patent infringement ...

PARIS/LONDON, Oct 5 (Reuters) - French drugmaker Sanofi-Aventis is preparing to sell its own generic version of the blockbuster heart medicine Plavix in France, a company spokesman said on Monday.

News of the expanded indication comes during a showdown between the marketer/manufacturer of the drug, Bristol-Myers Squibb (BMS)/Sanofi-Aventis, and Canadian drug company Apotex, which started ...

WASHINGTON (AP) – Cheaper generic versions of blood thinner Plavix, the world’s second-best-selling medicine, have just been approved for sale. The Food and Drug Administration says it’s given seven ...

The Justice Department is investigating a deal between two large brand-name drug makers and a generic company. The deal allegedly was made to keep a cheaper, generic form of Plavix off the market for ...

Bristol-Myers Squibb Co. (BMY) and Sanofi-Aventis (SNY) now have the upper hand in an upcoming patent trial over their blockbuster heart drug Plavix, if Thursday’s court injunction in the case is any ...